Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cabotegravir”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00812318
What this trial is testing

Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.

Who this might be right for
HIV InfectionInfection, Human Immunodeficiency Virus
ViiV Healthcare 45
Not applicableStudy completedNCT05867212
What this trial is testing

Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.

Who this might be right for
HIV Infections
Kelley-Ross & Associates, Inc. 50
Not applicableAvailableNCT03462810
What this trial is testing

GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIV

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare
Not applicableNot Yet RecruitingNCT07131826
What this trial is testing

The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine

Who this might be right for
Viral ControlQuality of LifeCabotegravir+2 more
National Taiwan University Clinical Trial Center 200
Testing effectiveness (Phase 2)Study completedNCT04692077
What this trial is testing

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 9
Not applicableEnded earlyNCT05096949
What this trial is testing

Implementing Cabenuva in Arkansas HIV Programs

Who this might be right for
HIV-1-infectionMedication AdherenceSatisfaction, Patient
University of Arkansas 1
Not applicableActive Not RecruitingNCT06468995
What this trial is testing

Antiviral Long Acting Drugs Landing in People Living With HIV

Who this might be right for
HIVAntiviral Agents
IRCCS San Raffaele 120
Not applicableLooking for participantsNCT05044962
What this trial is testing

Kuwa Free! - Live Free!

Who this might be right for
HIV InfectionsContraceptionDrug-drug Interaction
University of Alabama at Birmingham 700
Not applicableLooking for participantsNCT07727642
What this trial is testing

Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma

Who this might be right for
AIDS-related LymphomaHIV Infection
Shanghai Public Health Clinical Center 60
Not applicableLooking for participantsNCT06868641
What this trial is testing

The TAIL-PrEP Study

Who this might be right for
HIV Infections
Columbia University 30
Not applicableEnded earlyNCT05937698
What this trial is testing

The CATALYST Study

Who this might be right for
HIV Prevention
FHI 360 6,069
Early research (Phase 1)Study completedNCT01754116
What this trial is testing

Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 43
Large-scale testing (Phase 3)UnknownNCT06138600
What this trial is testing

Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa

Who this might be right for
HIV Infections
University of Witwatersrand, South Africa 200
Early research (Phase 1)Looking for participantsNCT05418868
What this trial is testing

Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 214
Testing effectiveness (Phase 2)WithdrawnNCT06657885
What this trial is testing

CAbotégravir LENacapavir DUal Long Acting

Who this might be right for
HIV1 InfectionMulti-treated Patients Who Have Received Multiple Lines of Antiretroviral TreatmentCABOTEGRAVIR+2 more
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Not applicableLooking for participantsNCT07370649
What this trial is testing

Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study

Who this might be right for
Human Immunodeficiency Virus (HIV)-1 InfectionHIV-1 Subtype A6 InfectionHIV-1 Subtype B Infection+1 more
Pomeranian Medical University Szczecin 250
Not applicableActive Not RecruitingNCT06518408
What this trial is testing

A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV

Who this might be right for
Human Immunodeficiency Virus
University Hospital Virgen de las Nieves 287
Early research (Phase 1)Active Not RecruitingNCT06970223
What this trial is testing

Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV

Who this might be right for
HIV Infections
ViiV Healthcare 65
Testing effectiveness (Phase 2)Study completedNCT02120352
What this trial is testing

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 309
Post-approval studies (Phase 4)Active Not RecruitingNCT05986084
What this trial is testing

Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana

Who this might be right for
Pre-Exposure Prophylaxis (PrEP)Breast Feeding
Beth Israel Deaconess Medical Center 500
Next Page